(Q54121244)

25 May 2018

title

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. (English)

1 reference

25 May 2018

0 references

1 reference

1 reference

Stern JJ

1

1 reference

25 May 2018

Hartman BJ

2

1 reference

25 May 2018

Sharkey P

3

1 reference

25 May 2018

Rowland V

4

1 reference

25 May 2018

Squires KE

5

1 reference

25 May 2018

Murray HW

6

1 reference

25 May 2018

Graybill JR

7

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 October 1988

1 reference

25 May 2018

American Journal of Medicine

published in

1 reference

25 May 2018

volume

85

1 reference

25 May 2018

issue

4

1 reference

25 May 2018

page(s)

477-480

1 reference

25 May 2018

Treatment of infections in patients with the acquired immunodeficiency syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Cryptococcosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Cryptococcal meningitis in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Strategies in the treatment of systemic fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Azole antifungal agents: emphasis on new triazoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Treatment of cryptococcal meningitis in mice with fluconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Capsule-deficient Cryptococcus neoformans in AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Cryptococcal meningitis and fluconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

Simplified bioassay method for measurement of flucytosine or ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980081-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(88)80081-0

1 reference

25 May 2018

PubMed ID

2845778

1 reference

25 May 2018